Evidence map›Paper›PMID 37095469›Full record

ArticleBMC musculoskeletal disorders2023

Transcriptome profiling of a synergistic volumetric muscle loss repair strategy.

Kevin Roberts, John Taehwan Kim, Tai Huynh, Jacob Schluns, Grady Dunlap, Jamie Hestekin, Jeffrey C Wolchok

Open access · goldAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Tissue Engineered 3D Constructs for Volumetric Muscle Loss.Annals of biomedical engineering · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kevin RobertsCell & Molecular Biology Program, University of Arkansas Fayetteville, Arkansas, USA.
John Taehwan KimDepartment of Biomedical Engineering, University of Arkansas Fayetteville, Arkansas, USA.
Tai HuynhDepartment of Biomedical Engineering, University of Arkansas Fayetteville, Arkansas, USA.
Jacob SchlunsDepartment of Biomedical Engineering, University of Arkansas Fayetteville, Arkansas, USA.
Grady DunlapDepartment of Biomedical Engineering, University of Arkansas Fayetteville, Arkansas, USA.
Jamie HestekinRalph E. Martin Department of Chemical Engineering, University of Arkansas Fayetteville, Arkansas, USA.
Jeffrey C WolchokDepartment of Biomedical Engineering, University of Arkansas Fayetteville, Arkansas, USA. jwolchok@uark.edu.
University of Arkansas at Fayetteville · US

Funding

Efficacy testing of an injectable matrix gel for the treatment of fatty muscle infiltrationR15AR073492 · NIAMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI WOLCHOK, JEFFREY · 2018 to 2018
$428k
NIAMS NIH HHS R15 AR073492NIAMS NIH HHS R15AR073492
6 · The paper itself

Abstract

Volumetric muscle loss overwhelms skeletal muscle's ordinarily capable regenerative machinery, resulting in severe functional deficits that have defied clinical repair strategies. In this manuscript we pair the early in vivo functional response induced by differing volumetric muscle loss tissue engineering repair strategies that are broadly representative of those explored by the field (scaffold alone, cells alone, or scaffold + cells) to the transcriptomic response induced by each intervention. We demonstrate that an implant strategy comprising allogeneic decellularized skeletal muscle scaffolds seeded with autologous minced muscle cellular paste (scaffold + cells) mediates a pattern of increased expression for several genes known to play roles in axon guidance and peripheral neuroregeneration, as well as several other key genes related to inflammation, phagocytosis, and extracellular matrix regulation. The upregulation of several key genes in the presence of both implant components suggests a unique synergy between scaffolding and cells in the early period following intervention that is not seen when either scaffolds or cells are used in isolation; a finding that invites further exploration of the interactions that could have a positive impact on the treatment of volumetric muscle loss.

Indexed as

Muscle, SkeletalTissue ScaffoldsExtracellular MatrixGene Expression ProfilingHumansRegenerationTissue EngineeringBiomaterial implantMuscle injury and repairPre-clinical animal model researchTranscriptomic profilingVolumeric muscle loss

Identifiers

PMID37095469
PMCPMC10124022
OpenAlexW4366825808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.